• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨杜氏肌营养不良症中的肠道微生物群-肌肉轴。

Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.

机构信息

Stem Cell Laboratory, Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.

Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

出版信息

Int J Mol Sci. 2024 May 21;25(11):5589. doi: 10.3390/ijms25115589.

DOI:10.3390/ijms25115589
PMID:38891777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11171690/
Abstract

The gut microbiota plays a pivotal role in maintaining the dynamic balance of intestinal epithelial and immune cells, crucial for overall organ homeostasis. Dysfunctions in these intricate relationships can lead to inflammation and contribute to the pathogenesis of various diseases. Recent findings uncovered the existence of a gut-muscle axis, revealing how alterations in the gut microbiota can disrupt regulatory mechanisms in muscular and adipose tissues, triggering immune-mediated inflammation. In the context of Duchenne muscular dystrophy (DMD), alterations in intestinal permeability stand as a potential origin of molecules that could trigger muscle degeneration via various pathways. Metabolites produced by gut bacteria, or fragments of bacteria themselves, may have the ability to migrate from the gut into the bloodstream and ultimately infiltrate distant muscle tissues, exacerbating localized pathologies. These insights highlight alternative pathological pathways in DMD beyond the musculoskeletal system, paving the way for nutraceutical supplementation as a potential adjuvant therapy. Understanding the complex interplay between the gut microbiota, immune system, and muscular health offers new perspectives for therapeutic interventions beyond conventional approaches to efficiently counteract the multifaceted nature of DMD.

摘要

肠道微生物群在维持肠道上皮细胞和免疫细胞的动态平衡中起着关键作用,这对整体器官稳态至关重要。这些复杂关系的功能障碍会导致炎症,并有助于各种疾病的发病机制。最近的发现揭示了肠道-肌肉轴的存在,揭示了肠道微生物群的改变如何破坏肌肉和脂肪组织中的调节机制,引发免疫介导的炎症。在杜氏肌营养不良症(DMD)中,肠道通透性的改变可能是通过多种途径引发肌肉退化的分子的潜在来源。肠道细菌产生的代谢物或细菌本身的片段可能有能力从肠道迁移到血液中,并最终渗透到远处的肌肉组织中,使局部病变恶化。这些观点强调了 DMD 中除肌肉骨骼系统以外的其他病理途径,为营养补充作为一种潜在的辅助治疗方法铺平了道路。了解肠道微生物群、免疫系统和肌肉健康之间的复杂相互作用,为超越传统方法的治疗干预提供了新的视角,从而有效地对抗 DMD 的多方面性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11171690/197703d04413/ijms-25-05589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11171690/197703d04413/ijms-25-05589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11171690/197703d04413/ijms-25-05589-g001.jpg

相似文献

1
Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.探讨杜氏肌营养不良症中的肠道微生物群-肌肉轴。
Int J Mol Sci. 2024 May 21;25(11):5589. doi: 10.3390/ijms25115589.
2
Microbes, metabolites and muscle: Is the gut-muscle axis a plausible therapeutic target in Duchenne muscular dystrophy?微生物、代谢物和肌肉:肠道-肌肉轴是否是杜氏肌营养不良症的一个合理治疗靶点?
Exp Physiol. 2023 Sep;108(9):1132-1143. doi: 10.1113/EP091063. Epub 2023 Jun 3.
3
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.mdx和dko营养不良小鼠以及杜氏肌营养不良症患者骨骼肌中Notch信号通路的改变。
Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.
4
Duchenne and Becker muscular dystrophy: Cellular mechanisms, image analysis, and computational models: A review.杜氏肌营养不良症和贝克肌营养不良症:细胞机制、图像分析和计算模型:综述。
Cytoskeleton (Hoboken). 2024 Jun-Jul;81(6-7):269-286. doi: 10.1002/cm.21826. Epub 2024 Jan 15.
5
Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review.推进杜氏肌营养不良症的生物标志物发现和治疗靶点:全面综述。
Int J Mol Sci. 2024 Jan 3;25(1):631. doi: 10.3390/ijms25010631.
6
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.炎症和氧化应激水平,以及牛磺酸在杜兴氏肌营养不良症的金毛寻回犬肌营养不良症模型的肌病病理学中的作用。
Redox Biol. 2016 Oct;9:276-286. doi: 10.1016/j.redox.2016.08.016. Epub 2016 Aug 30.
7
Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy.肌肉疾病发病机制中的生物钟及其对杜氏肌营养不良症的治疗潜力。
Int J Mol Sci. 2024 Apr 27;25(9):4767. doi: 10.3390/ijms25094767.
8
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.微生物失调会影响缺乏 dystrophin 的小鼠的免疫系统和肌肉病理生理学。
EMBO Mol Med. 2023 Mar 8;15(3):e16244. doi: 10.15252/emmm.202216244. Epub 2022 Dec 19.
9
Hypochlorous acid exposure impairs skeletal muscle function and Ca signalling: implications for Duchenne muscular dystrophy pathology.次氯酸暴露会损害骨骼肌功能和钙信号传导:对杜氏肌营养不良症病理的影响。
J Physiol. 2023 Dec;601(23):5257-5275. doi: 10.1113/JP285263. Epub 2023 Oct 21.
10
Understanding the process of fibrosis in Duchenne muscular dystrophy.了解杜氏肌营养不良症中的纤维化过程。
Biomed Res Int. 2014;2014:965631. doi: 10.1155/2014/965631. Epub 2014 May 4.

引用本文的文献

1
LF31 Supplementation Reversed Atrophy Fibers in a Model of Myopathy Through the Modulation of IL-6, TNF-α, and Hsp60 Levels Enhancing Muscle Regeneration.LF31补充剂通过调节白细胞介素-6、肿瘤坏死因子-α和热休克蛋白60水平增强肌肉再生,逆转了肌病模型中的萎缩纤维。
Nutrients. 2025 Apr 30;17(9):1550. doi: 10.3390/nu17091550.
2
Exploratory Analysis of Gut Microbiota Profile in Duchenne Muscular Dystrophy (DMD) Patients with Intellectual Disability.对患有智力残疾的杜氏肌营养不良症(DMD)患者肠道微生物群特征的探索性分析。
Mol Neurobiol. 2025 May 5. doi: 10.1007/s12035-025-04974-7.
3
Intestinal-pulmonary axis: a 'Force For Good' against respiratory viral infections.

本文引用的文献

1
Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia.肠道微生物群介导的色氨酸代谢对虚弱和肌少症中炎症老化的影响。
J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4). doi: 10.1093/gerona/glae044.
2
Insight into the Role of Gut Microbiota in Duchenne Muscular Dystrophy: An Age-Related Study in Mdx Mice.洞悉肠道微生物群在杜氏肌营养不良症中的作用:mdx 小鼠的一项年龄相关性研究。
Am J Pathol. 2024 Feb;194(2):264-279. doi: 10.1016/j.ajpath.2023.10.010. Epub 2023 Nov 20.
3
Fndc5/irisin deficiency leads to dysbiosis of gut microbiota contributing to the depressive-like behaviors in mice.
肠-肺轴:抵御呼吸道病毒感染的“有益力量”。
Front Immunol. 2025 Mar 18;16:1534241. doi: 10.3389/fimmu.2025.1534241. eCollection 2025.
Fndc5/irisin 缺乏导致肠道微生物群落失调,进而导致小鼠出现抑郁样行为。
Brain Res. 2023 Nov 15;1819:148537. doi: 10.1016/j.brainres.2023.148537. Epub 2023 Aug 15.
4
The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.微生物源短链脂肪酸对疾病中巨噬细胞活性的影响:作用机制与治疗潜力。
Biomed Pharmacother. 2023 Sep;165:115276. doi: 10.1016/j.biopha.2023.115276. Epub 2023 Aug 4.
5
Faecal microbiota transplantation from young rats attenuates age-related sarcopenia revealed by multiomics analysis.来自年轻大鼠的粪便微生物群移植可减轻多组学分析揭示的与年龄相关的肌肉减少症。
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2168-2183. doi: 10.1002/jcsm.13294. Epub 2023 Jul 13.
6
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies.杜氏肌营养不良症:疾病机制与治疗策略。
Front Physiol. 2023 Jun 26;14:1183101. doi: 10.3389/fphys.2023.1183101. eCollection 2023.
7
Polyamines and Physical Activity in Musculoskeletal Diseases: A Potential Therapeutic Challenge.多胺与肌肉骨骼疾病中的体力活动:潜在的治疗挑战。
Int J Mol Sci. 2023 Jun 6;24(12):9798. doi: 10.3390/ijms24129798.
8
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review.肠道微生物失调引起的炎症性疾病的免疫机制:综述。
Biomed Pharmacother. 2023 Aug;164:114985. doi: 10.1016/j.biopha.2023.114985. Epub 2023 Jun 11.
9
Microbes, metabolites and muscle: Is the gut-muscle axis a plausible therapeutic target in Duchenne muscular dystrophy?微生物、代谢物和肌肉:肠道-肌肉轴是否是杜氏肌营养不良症的一个合理治疗靶点?
Exp Physiol. 2023 Sep;108(9):1132-1143. doi: 10.1113/EP091063. Epub 2023 Jun 3.
10
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota.肠-肌肉轴与脓毒症相关性肌病:肠道微生物群的潜在作用。
Biomed Pharmacother. 2023 Jul;163:114837. doi: 10.1016/j.biopha.2023.114837. Epub 2023 May 8.